| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |